See Spot live longer: Antiaging pill for dogs clears key FDA hurdle
The start-up Loyal developed a pill to extend dogs’ lifespan that has been recognized by the FDA as having “reasonable ...
With RFK Jr. in charge, supplement makers see chance to cash in
Last fall, before being named the senior U.S. health official, Robert F. Kennedy Jr. said the Trump administration would ...
Ardelyx announces approval of NDA by China for tenapanor
Ardelyx (ARDX) announced the approval of a New Drug Application, NDA, by China’s Center for Drug Evaluation of the National Medical Products ...
Axsome Therapeutics to Participate in Upcoming Investor Conferences
TD Cowen 45th Annual Health Care Conference on March 4 in BostonLeerink Partners Global Biopharma Conference on March 12 in MiamiNEW YORK, Feb.
Le Lézard1d
FDA Approves First Human Milk-Based Fortifier for Term Infants to Support Growth and Recovery Following Surgery for Gastroschisis
Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products, today announced the U.S. Food and Drug Administration (FDA) has approved Surgifort® human milk ...
Endovascular Today1d
A New Innovation in Embolization: Merit Medical’s Microcatheter-Compatible Siege™ Vascular Plug
Embolization has made remarkable advances in recent years, becoming a widely adopted treatment option. The FDA approved the ...
6abc News1d
FDA delays when a final rule on what foods can be labeled as 'healthy' goes into effect
The US Food and Drug Administration's new standards for foods before they can be labeled as "healthy" on their packaging will ...
AFP2d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of ...
Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.
Next Generation Weight Loss Drugs Aim to Save Muscle
Some doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures.
Business Wire10d
FDA Approves Samsung Bioepis’ OSPOMYV™, XBRYK™ (denosumab-dssb), a Biosimilar to Prolia and Xgeva
Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYV™ (denosumab-dssb; ...